Dina Yassin, MD

    Molecular Biology Consultant and Head of Molecular Unit

Molecular Biology Consultant and Head of Molecular Unit

Prof. of Clinical Pathology, National Cancer Institute, Cairo University.


  • MD. Clinical pathology and Laboratory Oncologic Medicine , National Cancer Institute, Cairo.
  • MSc. Clinical and chemical Pathology, Faculty of Medicine.
  • BSc. Medicine and Surgery, Faculty of Medicine, Cairo University.

Selected Publications:

  • Sidhom I, Shaaban K, Soliman S, Ezzat S, El-Anwar W, Hamdy N, Yassin D, Salem S, Hassanein H and Mansour T. Clinical Significance of Immunophenotypic Markers in Pediatric T-cell Acute Lymphoblastic Leukemia. J. of the Egyptian National Cancer Institute vol 20, N0.2, June 2008.
  • Rania M. Labib, Mohamed E. A. Abdel Rahim, Enas Elnadi, Reem M. Hesham, Dina Yassin CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide. PLOS July 2016.
  • Clinical presentation and outcome of a child with Fanconi anemia and acute promyelocytic leukemia (APL): case report. February 2017 European Journal of Cancer.
  • Nesreen Ali, Seham Gohar, Iman Zaky, Ahmed Elghonemy,, Sarah Youssef, Gehad Sameer, Dina Yassin, Sherine Salem, Hadeel Magdi, Iman Sidhom. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children’s Cancer Hospital Egypt (CCHE) Pediatr Blood Cancer. August 2018.
  • Dina ElHarouni, Dina Yassin, Nesreen Ali, Seham Gohar, Iman Zaki, Eman Sidhom, Hassan Adwan, A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia. Frontiers in Oncol November 2018.
  • Maha Yehia, Dina Yassin, Hala Taha, Shahenda El Naga. Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma”. Scientific reports 2019.
  • Hanafy A. Hafez1, Amr Abdallah, Mahmoud Hammad, Nayera Hamdy, Dina Yassin, Sherine Salem, Omayma Hassanain, Lama Elhalaby, Alaa Elhaddad. Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience. Pediatric transplantation. January, 2020.